Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 35 | 2024 | 2420 | 2.500 |
Why?
|
Hypogonadism | 8 | 2024 | 799 | 1.970 |
Why?
|
Androgens | 11 | 2021 | 1281 | 1.300 |
Why?
|
Nicotinamide Mononucleotide | 2 | 2023 | 17 | 1.130 |
Why?
|
Sarcopenia | 7 | 2021 | 368 | 0.880 |
Why?
|
NAD | 3 | 2023 | 593 | 0.880 |
Why?
|
Muscle Strength | 7 | 2020 | 592 | 0.760 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2022 | 548 | 0.760 |
Why?
|
Erectile Dysfunction | 1 | 2024 | 461 | 0.710 |
Why?
|
Cardiovascular Diseases | 12 | 2024 | 15165 | 0.710 |
Why?
|
Hormone Replacement Therapy | 8 | 2024 | 745 | 0.690 |
Why?
|
Hand Strength | 5 | 2020 | 448 | 0.630 |
Why?
|
Receptors, Androgen | 2 | 2021 | 1058 | 0.600 |
Why?
|
Apolipoproteins B | 3 | 2023 | 374 | 0.580 |
Why?
|
Mobility Limitation | 6 | 2021 | 409 | 0.560 |
Why?
|
Body Composition | 9 | 2020 | 2401 | 0.550 |
Why?
|
Cholesterol, HDL | 6 | 2023 | 1814 | 0.550 |
Why?
|
Models, Theoretical | 2 | 2018 | 3589 | 0.480 |
Why?
|
Area Under Curve | 2 | 2018 | 1654 | 0.480 |
Why?
|
Anemia | 1 | 2023 | 1506 | 0.470 |
Why?
|
Malnutrition | 1 | 2020 | 625 | 0.450 |
Why?
|
Overweight | 2 | 2023 | 2371 | 0.430 |
Why?
|
Prostatectomy | 1 | 2021 | 1890 | 0.420 |
Why?
|
Insulin Resistance | 3 | 2023 | 3864 | 0.420 |
Why?
|
Renal Artery Obstruction | 3 | 2016 | 248 | 0.370 |
Why?
|
Risk Assessment | 10 | 2018 | 23338 | 0.370 |
Why?
|
Coronary Disease | 2 | 2023 | 6077 | 0.360 |
Why?
|
Aged | 49 | 2024 | 163280 | 0.350 |
Why?
|
Dietary Proteins | 3 | 2021 | 963 | 0.350 |
Why?
|
Consensus | 5 | 2020 | 2959 | 0.340 |
Why?
|
Double-Blind Method | 18 | 2023 | 12026 | 0.330 |
Why?
|
Myostatin | 2 | 2022 | 124 | 0.320 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11124 | 0.320 |
Why?
|
Middle Aged | 51 | 2024 | 213383 | 0.300 |
Why?
|
Muscle Weakness | 2 | 2020 | 413 | 0.300 |
Why?
|
Patient Readmission | 1 | 2020 | 3114 | 0.260 |
Why?
|
Cholesterol | 3 | 2023 | 2917 | 0.260 |
Why?
|
Male | 68 | 2024 | 350118 | 0.260 |
Why?
|
Heart | 1 | 2019 | 4467 | 0.260 |
Why?
|
Albuminuria | 3 | 2018 | 682 | 0.260 |
Why?
|
Spinal Cord Injuries | 2 | 2024 | 931 | 0.250 |
Why?
|
Cholesterol, LDL | 3 | 2023 | 2356 | 0.250 |
Why?
|
Muscle, Skeletal | 6 | 2022 | 4931 | 0.240 |
Why?
|
Humans | 78 | 2024 | 744343 | 0.230 |
Why?
|
Activities of Daily Living | 4 | 2021 | 2418 | 0.230 |
Why?
|
Exercise | 1 | 2019 | 5615 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 11725 | 0.220 |
Why?
|
Urinary Retention | 1 | 2023 | 111 | 0.220 |
Why?
|
Atherosclerosis | 5 | 2020 | 3445 | 0.220 |
Why?
|
Absorptiometry, Photon | 7 | 2024 | 1725 | 0.210 |
Why?
|
Aging | 6 | 2018 | 8664 | 0.200 |
Why?
|
Body Mass Index | 8 | 2023 | 12720 | 0.190 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 591 | 0.190 |
Why?
|
Tunica Media | 2 | 2011 | 113 | 0.190 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1869 | 0.190 |
Why?
|
Cohort Studies | 13 | 2022 | 40561 | 0.180 |
Why?
|
Carotid Artery, Common | 2 | 2011 | 183 | 0.180 |
Why?
|
Blood Glucose | 5 | 2022 | 6256 | 0.180 |
Why?
|
Stents | 3 | 2016 | 3280 | 0.180 |
Why?
|
Hypertriglyceridemia | 1 | 2023 | 293 | 0.180 |
Why?
|
Androgen Antagonists | 2 | 2018 | 1377 | 0.180 |
Why?
|
Lipoproteins | 2 | 2022 | 878 | 0.170 |
Why?
|
HIV Infections | 3 | 2022 | 16718 | 0.170 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1157 | 0.170 |
Why?
|
Tunica Intima | 2 | 2011 | 464 | 0.160 |
Why?
|
Prediabetic State | 1 | 2024 | 499 | 0.160 |
Why?
|
Particle Size | 1 | 2023 | 1642 | 0.160 |
Why?
|
Prostate-Specific Antigen | 3 | 2023 | 2494 | 0.150 |
Why?
|
Eunuchism | 1 | 2017 | 19 | 0.150 |
Why?
|
Agrin | 1 | 2017 | 68 | 0.150 |
Why?
|
Triglycerides | 2 | 2023 | 2454 | 0.150 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 128 | 0.150 |
Why?
|
Hemoglobins | 1 | 2023 | 1534 | 0.150 |
Why?
|
Dyslipidemias | 2 | 2018 | 849 | 0.150 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2017 | 62 | 0.150 |
Why?
|
Models, Cardiovascular | 2 | 2020 | 996 | 0.150 |
Why?
|
Leuprolide | 1 | 2018 | 321 | 0.140 |
Why?
|
Aorta, Abdominal | 2 | 2017 | 646 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 300 | 0.140 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 127 | 0.140 |
Why?
|
Physical Fitness | 2 | 2020 | 733 | 0.140 |
Why?
|
Body Weight | 3 | 2023 | 4669 | 0.140 |
Why?
|
Metabolome | 1 | 2023 | 895 | 0.140 |
Why?
|
Hysterectomy | 2 | 2019 | 927 | 0.140 |
Why?
|
Exercise Therapy | 2 | 2022 | 906 | 0.130 |
Why?
|
Finasteride | 1 | 2016 | 90 | 0.130 |
Why?
|
Independent Living | 4 | 2021 | 568 | 0.130 |
Why?
|
Risk Factors | 14 | 2023 | 72290 | 0.130 |
Why?
|
Female | 39 | 2023 | 380194 | 0.130 |
Why?
|
Mass Spectrometry | 1 | 2023 | 2203 | 0.130 |
Why?
|
Administration, Cutaneous | 4 | 2020 | 711 | 0.130 |
Why?
|
Erythrocyte Deformability | 1 | 2015 | 56 | 0.130 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2016 | 107 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 820 | 0.130 |
Why?
|
Gels | 3 | 2023 | 427 | 0.130 |
Why?
|
Exercise Test | 2 | 2020 | 2074 | 0.130 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 187 | 0.130 |
Why?
|
Blood Viscosity | 1 | 2015 | 124 | 0.130 |
Why?
|
Erythropoiesis | 1 | 2018 | 705 | 0.120 |
Why?
|
Chromatography, Liquid | 3 | 2022 | 976 | 0.120 |
Why?
|
Adult | 25 | 2024 | 214055 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 832 | 0.120 |
Why?
|
Sexual Behavior | 1 | 2024 | 2057 | 0.120 |
Why?
|
Erythropoietin | 1 | 2018 | 726 | 0.120 |
Why?
|
Life Support Care | 1 | 2015 | 228 | 0.120 |
Why?
|
Metabolism | 1 | 2015 | 196 | 0.120 |
Why?
|
Joints | 1 | 2015 | 326 | 0.120 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6487 | 0.120 |
Why?
|
Pulsatile Flow | 1 | 2014 | 332 | 0.110 |
Why?
|
Renal Dialysis | 1 | 2022 | 1786 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 541 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 12804 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2023 | 57776 | 0.110 |
Why?
|
Bone Resorption | 1 | 2017 | 723 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.110 |
Why?
|
Alopecia | 1 | 2016 | 382 | 0.110 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 570 | 0.110 |
Why?
|
Age Factors | 6 | 2020 | 18370 | 0.110 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2013 | 235 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 850 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2016 | 977 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 1947 | 0.100 |
Why?
|
Voice | 1 | 2015 | 259 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1591 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 984 | 0.100 |
Why?
|
Simian immunodeficiency virus | 1 | 2017 | 846 | 0.100 |
Why?
|
Spleen | 1 | 2017 | 2362 | 0.100 |
Why?
|
Glucose | 2 | 2024 | 4397 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2017 | 742 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2596 | 0.090 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 25043 | 0.090 |
Why?
|
Reproduction | 1 | 2015 | 668 | 0.090 |
Why?
|
Blood Pressure | 4 | 2016 | 8554 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1073 | 0.090 |
Why?
|
Prospective Studies | 8 | 2022 | 53288 | 0.090 |
Why?
|
Blood Platelets | 1 | 2020 | 2508 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2289 | 0.080 |
Why?
|
Calcinosis | 1 | 2018 | 1499 | 0.080 |
Why?
|
Neck | 1 | 2013 | 697 | 0.080 |
Why?
|
Microcomputers | 1 | 2008 | 147 | 0.080 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 458 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2170 | 0.080 |
Why?
|
Coronary Vessels | 2 | 2017 | 3107 | 0.080 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 445 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9849 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1922 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3255 | 0.080 |
Why?
|
Neutrophils | 1 | 2020 | 3719 | 0.080 |
Why?
|
Heart Septum | 1 | 2008 | 313 | 0.080 |
Why?
|
ROC Curve | 2 | 2012 | 3527 | 0.070 |
Why?
|
Health Status | 2 | 2018 | 4034 | 0.070 |
Why?
|
Clostridium Infections | 1 | 2014 | 548 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3297 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.070 |
Why?
|
Heart Rate | 1 | 2018 | 4091 | 0.070 |
Why?
|
Calcium | 2 | 2017 | 5756 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2014 | 1573 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.070 |
Why?
|
Sex Factors | 5 | 2020 | 10397 | 0.070 |
Why?
|
Treatment Outcome | 10 | 2022 | 63114 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 2208 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5097 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2019 | 2775 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6538 | 0.060 |
Why?
|
Obesity | 3 | 2023 | 12745 | 0.060 |
Why?
|
Phenotype | 1 | 2022 | 16365 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2569 | 0.060 |
Why?
|
Luteinizing Hormone | 2 | 2018 | 869 | 0.060 |
Why?
|
Lipids | 2 | 2018 | 3305 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 9959 | 0.060 |
Why?
|
Mental Health | 1 | 2018 | 3019 | 0.060 |
Why?
|
Computer Simulation | 2 | 2014 | 6196 | 0.060 |
Why?
|
Adiposity | 2 | 2014 | 1807 | 0.060 |
Why?
|
Cytokines | 1 | 2018 | 7322 | 0.060 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.060 |
Why?
|
Massachusetts | 5 | 2017 | 8663 | 0.060 |
Why?
|
Musculoskeletal Diseases | 1 | 2008 | 581 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3778 | 0.050 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2016 | 360 | 0.050 |
Why?
|
Hypertension | 5 | 2016 | 8480 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 1224 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.050 |
Why?
|
Accidental Falls | 2 | 2020 | 1062 | 0.050 |
Why?
|
Prevalence | 5 | 2020 | 15226 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1431 | 0.050 |
Why?
|
Hip Fractures | 2 | 2020 | 955 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7186 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7474 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 2872 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29063 | 0.050 |
Why?
|
Atrial Fibrillation | 3 | 2015 | 5034 | 0.050 |
Why?
|
Growth Differentiation Factors | 1 | 2022 | 98 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 35421 | 0.050 |
Why?
|
Organ Size | 2 | 2017 | 2252 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2009 | 1741 | 0.050 |
Why?
|
Time Factors | 6 | 2018 | 40075 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10943 | 0.050 |
Why?
|
Radius | 1 | 2024 | 422 | 0.050 |
Why?
|
Fatigue | 2 | 2018 | 1531 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12354 | 0.050 |
Why?
|
Logistic Models | 2 | 2012 | 13408 | 0.050 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 712 | 0.040 |
Why?
|
Lung | 1 | 2018 | 9856 | 0.040 |
Why?
|
Stroke | 3 | 2023 | 9981 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2008 | 1265 | 0.040 |
Why?
|
Echocardiography | 2 | 2010 | 5102 | 0.040 |
Why?
|
Insulin | 3 | 2018 | 6580 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2010 | 2073 | 0.040 |
Why?
|
Incidence | 5 | 2017 | 20947 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6770 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4644 | 0.040 |
Why?
|
Young Adult | 7 | 2022 | 56430 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2019 | 138 | 0.040 |
Why?
|
Disease Progression | 4 | 2018 | 13284 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 163 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2019 | 132 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10638 | 0.040 |
Why?
|
Reference Standards | 1 | 2022 | 1025 | 0.040 |
Why?
|
Tibia | 1 | 2024 | 1077 | 0.040 |
Why?
|
Bone Density | 2 | 2024 | 3468 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2065 | 0.040 |
Why?
|
Estradiol | 2 | 2015 | 2020 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2010 | 3821 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2018 | 378 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3670 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12245 | 0.040 |
Why?
|
Life Style | 1 | 2008 | 3835 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2019 | 77449 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15076 | 0.040 |
Why?
|
Prolactin | 1 | 2018 | 669 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2023 | 1660 | 0.030 |
Why?
|
Gait | 1 | 2021 | 793 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 590 | 0.030 |
Why?
|
Utah | 1 | 2015 | 126 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2017 | 39050 | 0.030 |
Why?
|
Estrous Cycle | 1 | 2015 | 73 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1150 | 0.030 |
Why?
|
Coronary Angiography | 2 | 2017 | 4577 | 0.030 |
Why?
|
Prostate | 1 | 2023 | 1774 | 0.030 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2015 | 112 | 0.030 |
Why?
|
Aortography | 1 | 2017 | 437 | 0.030 |
Why?
|
North America | 1 | 2018 | 1249 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1590 | 0.030 |
Why?
|
Viremia | 1 | 2018 | 736 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 550 | 0.030 |
Why?
|
Sound Spectrography | 1 | 2015 | 117 | 0.030 |
Why?
|
Reference Values | 1 | 2022 | 4982 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1270 | 0.030 |
Why?
|
Walking | 1 | 2021 | 1180 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1676 | 0.030 |
Why?
|
Hypertrophy | 1 | 2015 | 569 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1350 | 0.030 |
Why?
|
Aminoglycosides | 1 | 2014 | 162 | 0.030 |
Why?
|
Pelvis | 1 | 2018 | 730 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13989 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2015 | 3279 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2015 | 744 | 0.030 |
Why?
|
Systems Analysis | 1 | 2013 | 172 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2020 | 1827 | 0.030 |
Why?
|
Orchiectomy | 1 | 2015 | 474 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 661 | 0.030 |
Why?
|
Models, Statistical | 2 | 2020 | 5102 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1372 | 0.030 |
Why?
|
Manometry | 1 | 2014 | 445 | 0.030 |
Why?
|
Creatine | 1 | 2014 | 421 | 0.030 |
Why?
|
Europe | 1 | 2018 | 3339 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2015 | 575 | 0.030 |
Why?
|
Recovery of Function | 1 | 2022 | 2925 | 0.030 |
Why?
|
Voice Disorders | 1 | 2015 | 276 | 0.020 |
Why?
|
Tendons | 1 | 2015 | 548 | 0.020 |
Why?
|
HIV | 1 | 2018 | 1604 | 0.020 |
Why?
|
Ovary | 1 | 2015 | 981 | 0.020 |
Why?
|
Vancomycin | 1 | 2014 | 501 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2971 | 0.020 |
Why?
|
Muscles | 1 | 2015 | 1614 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2375 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1056 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 924 | 0.020 |
Why?
|
Extremities | 1 | 2015 | 865 | 0.020 |
Why?
|
Affect | 1 | 2018 | 1476 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1524 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4037 | 0.020 |
Why?
|
Femoral Artery | 1 | 2014 | 845 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2014 | 952 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11727 | 0.020 |
Why?
|
United States | 4 | 2020 | 69872 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2726 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3282 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1518 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2148 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 996 | 0.020 |
Why?
|
Osteogenesis | 1 | 2015 | 1299 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2015 | 1203 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15540 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3610 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 1082 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 12072 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 21827 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
Menopause | 1 | 2015 | 1626 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2948 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3396 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2505 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2455 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2714 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2008 | 391 | 0.020 |
Why?
|
Lung Diseases | 1 | 2015 | 1886 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3327 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2016 | 2071 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4199 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6442 | 0.010 |
Why?
|
Animals | 4 | 2017 | 168757 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2538 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7799 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6993 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2015 | 3966 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10252 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9687 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2373 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3674 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10180 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14557 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5952 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12261 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5985 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81183 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5751 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10262 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 85781 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7181 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14722 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|